Top compounds associated with response to B9D1


Feature Type Standardized
Nominal ANOVA
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.091 0.007
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.008
mRNA PF-543 CTRPv2 pan-cancer AAC -0.1 0.009
mRNA lapatinib gCSI pan-cancer AAC -0.14 0.009
mRNA JQ12 GDSC1000 pan-cancer AAC -0.1 0.01
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA STF-62247 GDSC1000 pan-cancer AAC -0.091 0.01
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.01
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.085 0.01
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.094 0.01
Download CSV